Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshiaki Watanabe

Showing results (91-100 of 104) with videos related to

Pageof 11
Sort By:
Journal of Medicinal Chemistry|February 6, 2020
Lead Optimization and Avoidance of Reactive Metabolite Leading to PCO371, a Potent, Selective, and Orally Available Human Parathyroid Hormone Receptor 1 (hPTHR1) AgonistYoshikazu Nishimura, Toru Esaki, Yoshiaki Isshiki, et al.
Bioorganic & Medicinal Chemistry Letters|August 5, 2008
Factor VIIa inhibitors: target hopping in the serine protease family using X-ray structure determinationTakuya Shiraishi, Shojiro Kadono, Masayuki Haramura, et al.
Chemical & Pharmaceutical Bulletin|January 5, 2010
Design and synthesis of peptidomimetic factor VIIa inhibitorsTakuya Shiraishi, Shojiro Kadono, Masayuki Haramura, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|March 3, 2006
Structure of human factor VIIa/tissue factor in complex with a peptide-mimetic inhibitor: high selectivity against thrombin by introducing two charged groups in P2 and P4Shojiro Kadono, Akihisa Sakamoto, Yasufumi Kikuchi, et al.
Brain & Development|March 31, 2009
Comprehensive genetic analyses of PLP1 in patients with Pelizaeus-Merzbacher disease applied by array-CGH and fiber-FISH analyses identified new mutations and variable sizes of duplicationsKeiko Shimojima, Takehiko Inoue, Ai Hoshino, et al.
Journal of Cardiovascular Electrophysiology|July 11, 2020
Lesion characteristics between cryoballoon ablation and radiofrequency ablation with a contact force-sensing catheter: Late-gadolinium enhancement magnetic resonance imaging assessmentJun Kurose, Kunihiko Kiuchi, Koji Fukuzawa, et al.
Journal of Cardiovascular Electrophysiology|February 3, 2021
Circulating intermediate monocytes and atrial structural remodeling associated with atrial fibrillation recurrence after catheter ablationHideya Suehiro, Kunihiko Kiuchi, Koji Fukuzawa, et al.
Journal of Cardiovascular Electrophysiology|February 8, 2021
Late-gadolinium enhancement properties associated with atrial fibrillation rotors in patients with persistent atrial fibrillationToshihiro Nakamura, Kunihiko Kiuchi, Koji Fukuzawa, et al.
Journal of Arrhythmia|April 7, 2022
The impact of the atrial wall thickness in normal/mild late-gadolinium enhancement areas on atrial fibrillation rotors in persistent atrial fibrillation patientsToshihiro Nakamura, Kunihiko Kiuchi, Koji Fukuzawa, et al.
Biochemical and Biophysical Research Communications|December 21, 2004
Novel interactions of large P3 moiety and small P4 moiety in the binding of the peptide mimetic factor VIIa inhibitorShojiro Kadono, Akihisa Sakamoto, Yasufumi Kikuchi, et al.
Pageof 11

Showing results (91-100 of 104) with videos related to

Sort By:
Pageof 11
Journal of Medicinal Chemistry|February 6, 2020
Lead Optimization and Avoidance of Reactive Metabolite Leading to PCO371, a Potent, Selective, and Orally Available Human Parathyroid Hormone Receptor 1 (hPTHR1) AgonistYoshikazu Nishimura, Toru Esaki, Yoshiaki Isshiki, et al.
Bioorganic & Medicinal Chemistry Letters|August 5, 2008
Factor VIIa inhibitors: target hopping in the serine protease family using X-ray structure determinationTakuya Shiraishi, Shojiro Kadono, Masayuki Haramura, et al.
Chemical & Pharmaceutical Bulletin|January 5, 2010
Design and synthesis of peptidomimetic factor VIIa inhibitorsTakuya Shiraishi, Shojiro Kadono, Masayuki Haramura, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|March 3, 2006
Structure of human factor VIIa/tissue factor in complex with a peptide-mimetic inhibitor: high selectivity against thrombin by introducing two charged groups in P2 and P4Shojiro Kadono, Akihisa Sakamoto, Yasufumi Kikuchi, et al.
Brain & Development|March 31, 2009
Comprehensive genetic analyses of PLP1 in patients with Pelizaeus-Merzbacher disease applied by array-CGH and fiber-FISH analyses identified new mutations and variable sizes of duplicationsKeiko Shimojima, Takehiko Inoue, Ai Hoshino, et al.
Journal of Cardiovascular Electrophysiology|July 11, 2020
Lesion characteristics between cryoballoon ablation and radiofrequency ablation with a contact force-sensing catheter: Late-gadolinium enhancement magnetic resonance imaging assessmentJun Kurose, Kunihiko Kiuchi, Koji Fukuzawa, et al.
Journal of Cardiovascular Electrophysiology|February 3, 2021
Circulating intermediate monocytes and atrial structural remodeling associated with atrial fibrillation recurrence after catheter ablationHideya Suehiro, Kunihiko Kiuchi, Koji Fukuzawa, et al.
Journal of Cardiovascular Electrophysiology|February 8, 2021
Late-gadolinium enhancement properties associated with atrial fibrillation rotors in patients with persistent atrial fibrillationToshihiro Nakamura, Kunihiko Kiuchi, Koji Fukuzawa, et al.
Journal of Arrhythmia|April 7, 2022
The impact of the atrial wall thickness in normal/mild late-gadolinium enhancement areas on atrial fibrillation rotors in persistent atrial fibrillation patientsToshihiro Nakamura, Kunihiko Kiuchi, Koji Fukuzawa, et al.
Biochemical and Biophysical Research Communications|December 21, 2004
Novel interactions of large P3 moiety and small P4 moiety in the binding of the peptide mimetic factor VIIa inhibitorShojiro Kadono, Akihisa Sakamoto, Yasufumi Kikuchi, et al.
Pageof 11